Učitavanje...
Development and prevalence of castration-resistant prostate cancer subtypes
BACKGROUND: Castration-resistant prostate cancer (CRPC) occurs when prostate cancer (CaP) progresses under therapy-induced castrate conditions. Several mechanisms have been proposed to explain this acquired resistance, many of which are driven by androgen receptor (AR). Recent findings, however, sub...
Spremljeno u:
| Izdano u: | Neoplasia |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Neoplasia Press
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7522286/ https://ncbi.nlm.nih.gov/pubmed/32980775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2020.09.002 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|